
BioTime of Alameda has appointed Adi Mohanty as co-CEO. (LinkedIn)
Mohanty joined BioTime in December, 2014, from Shire plc in San Diego.
According to a BioTime media release, Dr. West will lead BioTime’s science, technology development, and intellectual property activities with a particular focus on growing the company’s discovery and pre-clinical product development programs and Mohanty will lead the company’s advanced clinical development programs and commercialization strategies, as well as assume leadership of its corporate and administrative activities.
Both will report to the company’s Board of Directors.
Recent Comments